Fortress Biotech, Inc. Finite-lived Intangible Assets Acquired
Fortress Biotech, Inc. (FBIO) reported Finite-lived Intangible Assets Acquired of $7.13 million for the 12-month period ending 2019-12-31, per its 10-K/A filed 2021-04-09.
Discontinued › Notes › Goodwill and Other
us-gaap:FinitelivedIntangibleAssetsAcquired1 · last filed 2021-04-09
- Fortress Biotech, Inc. finite-lived intangible assets acquired for fiscal 2019 was $7.13M.
| Period end | Finite-lived Intangible Assets Acquired 6 month | Finite-lived Intangible Assets Acquired 12 month |
|---|---|---|
| 2019-12-31 | $7.13M 10-K/A · filed 2021-04-09 | |
| 2018-06-30 | $45.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |